GPX4 and neoplasm: The classic ferroptosis inducers erastin and RSL3 were initially identified by screening small molecule compounds able to suppress oncogenic RAS mutation-driven tumor growth and were later found to block the antioxidant system relying on xc−-glutathione peroxidase 4 (GPX4)5,6.